Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
Rev Esp Cardiol (Engl Ed). 2024 Aug;77(8):634-644.
doi: 10.1016/j.rec.2024.01.001.
Epub 2024 Jan 29.
[Article in
English,
Spanish]
Authors
Marta Maccallini
1
, Gonzalo Barge-Caballero
2
, Eduardo Barge-Caballero
3
, Manuel López-Pérez
4
, Raquel Bilbao-Quesada
5
, Eva González-Babarro
6
, Inés Gómez-Otero
7
, Andrea López-López
8
, Mario Gutiérrez-Feijoo
9
, Alfonso Varela-Román
7
, Javier García-Seara
10
, Alberto Bouzas-Mosquera
2
, María G Crespo-Leiro
2
Affiliations
- 1 Department of Internal Medicine, IRCCS Humanitas Research Hospital, Milan, Italy.
- 2 Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.
- 3 Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address: eduardo.barge.caballero@sergas.es.
- 4 Servicio de Cardiología, Complexo Hospitalario Universitario de Ferrol (CHUF), Servicio Galego de Saúde (SERGAS), Ferrol, A Coruña, Spain.
- 5 Servicio de Cardiología, Complexo Hospitalario Universitario de Vigo (CHUVI), Servicio Galego de Saúde (SERGAS), Vigo, Pontevedra, Spain.
- 6 Servicio de Cardiología, Complexo Hospitalario Universitario de Pontevedra (CHOP), Servicio Galego de Saúde (SERGAS), Pontevedra, Spain.
- 7 Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servicio Galego de Saúde (SERGAS), Santiago de Compostela, A Coruña, Spain.
- 8 Servicio de Cardiología, Hospital Universitario Lucus Augusti (HULA), Servicio Galego de Saúde (SERGAS), Lugo, Spain.
- 9 Servicio de Cardiología, Complexo Hospitalario Universitario de Ourense (CHUOU), Servicio Galego de Saúde (SERGAS), Ourense, Spain.
- 10 Servicio de Cardiología, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servicio Galego de Saúde (SERGAS), Santiago de Compostela, A Coruña, Spain.
Abstract
Introduction and objectives:
The tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio is a noninvasive surrogate of right ventricular to pulmonary circulation that has prognostic implications in patients with heart failure (HF) or pulmonary hypertension. Our purpose was to evaluate the prognostic value of the TAPSE/SPAP ratio in patients with cardiac amyloidosis.
Methods:
We used the database of the AMIGAL study, a prospective, observational registry of patients with cardiac amyloidosis recruited in 7 hospitals of the Autonomous Community of Galicia, Spain, from January 1, 2018 to October 31, 2022. We selected patients whose baseline TAPSE/SPAP ratio was calculated with transthoracic echocardiography. Long-term survival and survival free of HF hospitalization were assessed by means of 5 different multivariable Cox regression models. Median follow-up was 680 days.
Results:
We studied 233 patients with cardiac amyloidosis, among whom 209 (89.7%) had transthyretin type. The baseline TAPSE/SPAP ratio correlated significantly with clinical outcomes. Depending on the multivariable model considered, the adjusted hazard ratios estimated per 0.1mm/mmHg increase of baseline TAPSE/SPAP ratio ranged from 0.76 to 0.84 for all-cause mortality. Similarly, the ratios for all-cause mortality of HF hospitalization ranged from 0.79 to 0.84. The addition of the baseline TAPSE/SPAP ratio to the predictive model of the United Kingdom National Amyloidosis Centre resulted in an increase in Harrell's c-statistic from 0.662 to 0.705 for all-cause mortality and from 0.668 to 0.707 for all-cause mortality or HF hospitalization.
Conclusions:
Reduced TAPSE/SPAP ratio is an independent adverse prognostic marker in patients with cardiac amyloidosis.
Keywords:
Acoplamiento ventriculoarterial; Amiloidosis cardiaca; Cardiac amyloidosis; Desplazamiento sistólico del plano del anillo tricuspídeo; Función del ventrículo derecho; Presión arterial pulmonar sistólica; Right ventricular function; Systolic pulmonary artery pressure; Tricuspid annular plane systolic excursion; Ventriculoarterial coupling.
Copyright © 2024 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
Publication types
-
Observational Study
-
Multicenter Study
MeSH terms
-
Aged
-
Aged, 80 and over
-
Amyloidosis* / diagnosis
-
Amyloidosis* / mortality
-
Amyloidosis* / physiopathology
-
Cardiomyopathies / diagnosis
-
Cardiomyopathies / physiopathology
-
Echocardiography* / methods
-
Female
-
Follow-Up Studies
-
Humans
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / physiopathology
-
Male
-
Middle Aged
-
Prognosis
-
Prospective Studies
-
Pulmonary Artery* / diagnostic imaging
-
Pulmonary Artery* / physiopathology
-
Pulmonary Wedge Pressure / physiology
-
Registries
-
Spain / epidemiology
-
Survival Rate / trends
-
Systole
-
Tricuspid Valve / diagnostic imaging
-
Tricuspid Valve / physiopathology